Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 3 Clinicopathological features of patients with breast cancer included in the study

From: Plasma exosome microRNAs are indicative of breast cancer

Plasma sample Age ER status PR status HER2 status Grade Stagea
PL7 48 - + - 3 NA
PL8 67 + + - 2 IIA
PL9 56 + - - 2 NA
PL10 56 + + - 3 IIB
PL11 63 + + - 1 IA
PL12 53 + + - 3 NA
PL13 51 NA NA NA 3 IIIA
PL14 52 - - +   0
PL15 71 + + - 2/1 IA
PL16 80 + + - 2 IIA
PL17 75 + - +   NA
PL18 51 + + - 1 IIA
PL19 68 + + - 3 IIB
PL20 56 + + + 2 NA
PL21 65 + + - 2 NA
PL22 42 + + - 2 IIA
Mean age 59.6      
Median age 56.0      
  1. aPathologic TNM tumor staging, (American Joint Committee on Cancer Care 7th Edition). ER estrogen receptor, PR progesterone receptor, HER2 human epidermal growth factor receptor 2 amplification, NA not available